A federal judge on Wednesday ordered the drugmaker Novo Nordisk to pay $3 billion in damages, one of the highest-ever verdicts for a medical malpractice case. The company will also be required to change its marketing practices and correct safety complaints that have been raised by doctors since 2009.
The “is invokana being taken off the market” is a question that has been asked by many people. The answer is no, Invokana is not being taken off the market.
(This page was last updated on November 8, 2018)
Please note that we no longer accept Invokana and Invokamet cases.
In October 2018, Johnson & Johnson and their subsidiary Janssen agreed to settle a large portion of the 1,000 Invokana lawsuits filed against them in a New Jersey multidistrict litigation (MDL). It’s unclear how many lawsuits the confidential settlement fund will cover.
Invokana and Invokamet are accused of causing diabetic ketoacidosis, acute renal damage, and amputation injuries, according to the complaints.
In June 2016, more than three years after Invokana’s FDA approval in March 2013, the FDA added ketoacidosis warnings to Invokana, Invokamet, Farxiga, and Xigduo XR (all SGLT2 inhibitors). Despite the FDA’s belief that the danger of ketoacidosis was significant enough to warrant a warning, lawsuits question why Janssen didn’t disclose the risk on their medicine labels from the start.
Confidential Settlement with Invokana in 2018
A motion filed on October 16, 2018 revealed that Johnson & Johnson and its subsidiary Janssen had agreed to establish a confidential settlement fund that would resolve most of the 1,000 lawsuits filed against them in a New Jersey MDL. It’s likely the companies will also settle the lawsuits pending in Pennsylvania and California state courts.
Plaintiffs in the Actos case have reached a $2.4 billion settlement.
Though it’s hard to estimate how much compensation Invokana claimants will get through the settlement or in court, it’s likely to be substantial. Takeda, a Japanese pharmaceutical firm, resolved litigation over its Type 2 diabetes medicine Actos for $2.37 billion in 2015. (Actos has been connected to the development of bladder cancer.)
Terrance Allen, an Actos user who acquired bladder cancer, was awarded $6 billion by a Louisiana jury in 2014. (The judgment was eventually lowered to $38.6 million by a court.)
Have you been harmed by a drug? We Can Assist
You may be eligible to initiate a case against the producers if you were wounded by a pharmaceutical medication. Lawsuits may help you be paid for past and future medical costs, lost wages, pain and suffering, and other expenses.
Our attorneys have taken on the most powerful pharmaceutical giants in the country, including Johnson & Johnson and Bayer, and have the skills and resources to take your case. Contact us today for a free, no-obligation legal review. It never costs a thing unless we win a jury award or settlement for you.
Watch This Video-
Frequently Asked Questions
When will Invokana lawsuit be settled?
A: The lawsuit was recently dismissed by Judge Dieter J. Schroeder on February 14th, 2019. He found that the defendants failed to prove that they had a product at issue as opposed to simply information about it and/or instructions for obtaining it. As such, he ruled in favor of plaintiffs who alleged infringement under the First Amendment against Invokana.
Are there any lawsuits against Invokana?
A: There are currently no lawsuits against Invokana. If you have filed a lawsuit, please contact the Court for further information about this issue.
Why was Invokana taken off the market?
A: Invokana was pulled from the market in 2018 after it was found that many people experienced serious and potentially life-threatening side effects.
- jardiance lawsuit settlements
- invokana class action
- invokana side effects